Menu
Search
|

Menu

Close
X

Repligen Corp RGEN.OQ (NASDAQ Stock Exchange Global Select Market)

61.50 USD
+0.00 (+0.00%)
As of Nov 20
chart
Previous Close 61.50
Open 61.40
Volume 133,250
3m Avg Volume 147,330
Today’s High 62.73
Today’s Low 61.05
52 Week High 70.47
52 Week Low 29.58
Shares Outstanding (mil) 43.51
Market Capitalization (mil) 1,667.74
Forward P/E 75.20
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.90 Mean rating from 10 analysts

KEY STATS

Revenue (mm, USD)
FY18
142
FY17
141
FY16
105
FY15
84
EPS (USD)
FY18
0.243
FY17
0.498
FY16
0.342
FY15
0.278
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
75.20
33.59
Price to Sales (TTM)
vs sector
14.72
5.69
Price to Book (MRQ)
vs sector
6.85
5.11
Price to Cash Flow (TTM)
vs sector
69.96
23.52
Total Debt to Equity (MRQ)
vs sector
50.92
15.71
LT Debt to Equity (MRQ)
vs sector
50.92
11.53
Return on Investment (TTM)
vs sector
6.40
15.05
Return on Equity (TTM)
vs sector
9.98
16.62

EXECUTIVE LEADERSHIP

Karen Dawes
Independent Chairperson of the Board, Since 2011
Salary: --
Bonus: --
Anthony Hunt
President, Chief Executive Officer, Director, Since 2015
Salary: $550,000.00
Bonus: --
Jon Snodgres
Chief Financial Officer, Since 2014
Salary: $350,097.00
Bonus: --
Ralf Kuriyel
Senior Vice President, Research and Development, Since 2016
Salary: --
Bonus: --
Nicolas Barthelemy
Independent Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

41 Seyon St Bldg 1 Ste 100
WALTHAM   MA   02453-8348

Phone: +1781.4499560

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.

SPONSORED STORIES